Cargando…

An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression

Hepatitis B virus (HBV) contains three surface glycoproteins—Large-HBs (L-HBs), Middle-HBs (M-HBs), and Small-HBs (S-HBs), known to contribute to HBV-driven pro-oncogenic properties. Here, we examined the kinetics of HBs-isoforms in virologically-suppressed patients who developed or did not develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brancaccio, Giuseppina, Salpini, Romina, Piermatteo, Lorenzo, Surdo, Matteo, Fini, Vanessa, Colagrossi, Luna, Cantone, Marco, Battisti, Arianna, Oda, Yasunori, Di Carlo, Domenico, Ceccherini-Silberstein, Francesca, Perno, Carlo Federico, Gaeta, Giovanni Battista, Svicher, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065957/ https://www.ncbi.nlm.nih.gov/pubmed/33918474 http://dx.doi.org/10.3390/microorganisms9040752

Ejemplares similares

Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B
por: Svicher, Valentina, et al.
Publicado: (2021)

High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance
por: Malagnino, Vincenzo, et al.
Publicado: (2018)

A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition In Vitro
por: Salpini, Romina, et al.
Publicado: (2020)

Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
por: Cerva, Carlotta, et al.
Publicado: (2022)

New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis
por: Svicher, Valentina, et al.
Publicado: (2023)

Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers
por: Salpini, Romina, et al.
Publicado: (2020)

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets
por: Colagrossi, Luna, et al.
Publicado: (2018)

Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage
por: Borrajo, Ana, et al.
Publicado: (2019)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
por: Salpini, Romina, et al.
Publicado: (2020)

SARS-CoV-2 Mutations and Variants May Muddle the Sensitivity of COVID-19 Diagnostic Assays
por: Alkhatib, Mohammad, et al.
Publicado: (2022)

HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
por: Piermatteo, Lorenzo, et al.
Publicado: (2021)

SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021
por: Alkhatib, Mohammad, et al.
Publicado: (2021)

Selected amino acid mutations in HIV-1 B subtype gp41 are Associated with Specific gp120(V3 )signatures in the regulation of Co-Receptor usage
por: Dimonte, Salvatore, et al.
Publicado: (2011)

New Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised Hosts
por: Svicher, Valentina, et al.
Publicado: (2019)

Inhibition of Dual/Mixed Tropic HIV-1 Isolates by CCR5-Inhibitors in Primary Lymphocytes and Macrophages
por: Surdo, Matteo, et al.
Publicado: (2013)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
por: Piermatteo, Lorenzo, et al.
Publicado: (2023)

Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile
por: Alkhatib, Mohammad, et al.
Publicado: (2022)

Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure
por: Salpini, Romina, et al.
Publicado: (2022)

Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?
por: Brancaccio, Giuseppina, et al.
Publicado: (2020)

HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors
por: Cento, Valeria, et al.
Publicado: (2012)

Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal
por: Cerva, C., et al.
Publicado: (2017)

NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients
por: Bellocchi, Maria Concetta, et al.
Publicado: (2019)

Multicenter Evaluation of the Cepheid Xpert(®) HBV Viral Load Test
por: Marcuccilli, Fabbio, et al.
Publicado: (2021)

Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis
por: Scutari, Rossana, et al.
Publicado: (2020)

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
por: Colagrossi, Luna, et al.
Publicado: (2018)

Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
por: Artese, Anna, et al.
Publicado: (2020)

Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation Sequencing
por: Bellocchi, Maria Concetta, et al.
Publicado: (2023)

Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach
por: Romeo, Isabella, et al.
Publicado: (2022)

Hepatitis B–Related Hepatic Flare During Immune Reconstitution Syndrome After Antiretroviral Treatment Initiation in an HBV Surface Antigen–Positive Patient With HIV: Viroimmunological and Histological Characterization
por: Iannetta, Marco, et al.
Publicado: (2022)

Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection
por: Borrajo, Ana, et al.
Publicado: (2021)

Description of the L76V Resistance Protease Mutation in HIV-1 B and “Non-B” Subtypes
por: Charpentier, Charlotte, et al.
Publicado: (2013)

HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy
por: Malagnino, Vincenzo, et al.
Publicado: (2019)

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon
por: Takou, Desire, et al.
Publicado: (2019)

Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro
por: Salpini, Romina, et al.
Publicado: (2017)

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
por: Semengue, Ezechiel Ngoufack Jagni, et al.
Publicado: (2022)

Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients
por: Gratteri, Carmen, et al.
Publicado: (2023)

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs
por: Alteri, Claudia, et al.
Publicado: (2009)

HIV eradication: virological chances and clinical perspectives
por: Perno, C
Publicado: (2012)

HIV-HBV Coinfection—Current Challenges for Virologic Monitoring
por: Ruta, Simona, et al.
Publicado: (2023)

The Role of HIV Infection in Neurologic Injury
por: Scutari, Rossana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eisqd0qthtiqfb85kndplo4c94